EW vs NABL · P/E 47, rev $1.39B vs P/E 103, rev $466.1M
Edwards Lifesciences Corp (EW) versus N-Able Inc (NABL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
N-Able Inc (NABL) is a information technology services company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported NABL revenue for 2024-12-31 was $466.1M. Net income was $31.0M. Revenue was up 10.5% from 2023-12-31 to 2024-12-31. NABL currently screens at market cap $1.56B and trailing P/E 103.1.
EW currently screens at market cap $49.91B and trailing P/E 46.9. NABL currently screens at market cap $1.56B and trailing P/E 103.1.
Not investment advice. Open the EW and NABL stock pages for the full models.
Not investment advice.